<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Собрание:</title>
  <link rel="alternate" href="http://dspace.nuph.edu.ua/handle/123456789/1147" />
  <subtitle />
  <id>http://dspace.nuph.edu.ua/handle/123456789/1147</id>
  <updated>2026-07-20T13:07:05Z</updated>
  <dc:date>2026-07-20T13:07:05Z</dc:date>
  <entry>
    <title>Promising biological targets for the design of multitarget neuromodulatory agents</title>
    <link rel="alternate" href="http://dspace.nuph.edu.ua/handle/123456789/37144" />
    <author>
      <name>Bespalenko, D.</name>
    </author>
    <author>
      <name>Velgan, R.</name>
    </author>
    <author>
      <name>Severina, H.</name>
    </author>
    <author>
      <name>Georgiyants, V.</name>
    </author>
    <id>http://dspace.nuph.edu.ua/handle/123456789/37144</id>
    <updated>2026-07-13T13:34:49Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Название: Promising biological targets for the design of multitarget neuromodulatory agents
Авторы: Bespalenko, D.; Velgan, R.; Severina, H.; Georgiyants, V.
Краткий осмотр (реферат): Neuropsychiatric and neurodegenerative disorders, including depression and cognitive&#xD;
impairment, are characterized by complex multifactorial pathophysiology involving dysregulation of&#xD;
multiple neurotransmitter systems, impaired neuroplasticity, and neuroinflammatory processes.&#xD;
Traditional pharmacotherapy targeting a single biological target often demonstrates limited&#xD;
therapeutic efficacy. Therefore, increasing attention has been paid to the concept of multitargetdirected ligands (MTDLs), which involves the design of compounds capable of modulating several&#xD;
key biological targets within the central nervous system simultaneously [1].</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Non-aqueous DPPH spectrophotometric assay for evaluating lipophilic compounds with tocopherol acetate calibration</title>
    <link rel="alternate" href="http://dspace.nuph.edu.ua/handle/123456789/37143" />
    <author>
      <name>Matus, T.</name>
    </author>
    <author>
      <name>Ivanauskas, L.</name>
    </author>
    <author>
      <name>Marksa, M.</name>
    </author>
    <author>
      <name>Georgiyants, V.</name>
    </author>
    <id>http://dspace.nuph.edu.ua/handle/123456789/37143</id>
    <updated>2026-07-13T13:22:47Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Название: Non-aqueous DPPH spectrophotometric assay for evaluating lipophilic compounds with tocopherol acetate calibration
Авторы: Matus, T.; Ivanauskas, L.; Marksa, M.; Georgiyants, V.
Краткий осмотр (реферат): For assessing antioxidant activity of hydrophilic and lipophilic compounds, hydrophilic&#xD;
standards (Trolox, ascorbic acid, gallic acid, rutin, etc.) are most commonly used in&#xD;
spectrophotometric studies. However, for lipophilic substances, it is more appropriate to perform the&#xD;
analysis in non-aqueous conditions and compare their activity with a lipophilic standard. α‑Tocopherol&#xD;
serves as such a standard, demonstrating activity comparable to Trolox (1). Therefore, a DPPH-based&#xD;
method in a non-aqueous medium was developed using α‑tocopherol as a standard and applied to&#xD;
chamomile essential oil</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Prospects for Implementing Continuous Flow Reactors for the Industrial Synthesis of APIs Based on Organometallic Reagents</title>
    <link rel="alternate" href="http://dspace.nuph.edu.ua/handle/123456789/37142" />
    <author>
      <name>Vernydub, M.</name>
    </author>
    <author>
      <name>Georgiyants, V.</name>
    </author>
    <id>http://dspace.nuph.edu.ua/handle/123456789/37142</id>
    <updated>2026-07-13T13:17:12Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Название: Prospects for Implementing Continuous Flow Reactors for the Industrial Synthesis of APIs Based on Organometallic Reagents
Авторы: Vernydub, M.; Georgiyants, V.
Краткий осмотр (реферат): The modern pharmaceutical industry requires the implementation of highly efficient&#xD;
synthesis methods for active pharmaceutical ingredients (APIs) based on "green chemistry" and&#xD;
safety. Using highly reactive organometallic reagents like n-butyllithium in traditional batch processes&#xD;
poses risks of thermal runaway, necessitating extreme cooling (-78 °C) and high energy costs.&#xD;
Continuous flow reactors offer a solution to reduce technological hazards and increase efficiency for&#xD;
such dangerous industrial-scale syntheses</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Selection of conditions for impurities’ determination in combined ibuprofen/caffeine syrup by HPLC</title>
    <link rel="alternate" href="http://dspace.nuph.edu.ua/handle/123456789/37141" />
    <author>
      <name>Surzhikov, I.</name>
    </author>
    <author>
      <name>Chornyi, V.</name>
    </author>
    <author>
      <name>Georgiyants, V.</name>
    </author>
    <id>http://dspace.nuph.edu.ua/handle/123456789/37141</id>
    <updated>2026-07-13T13:09:11Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Название: Selection of conditions for impurities’ determination in combined ibuprofen/caffeine syrup by HPLC
Авторы: Surzhikov, I.; Chornyi, V.; Georgiyants, V.
Краткий осмотр (реферат): The production of fixed combinations is a modern trend in pharmaceutical manufacturing&#xD;
due to their advantages (1). Recently, a fairly large number of ibuprofen combinations have been&#xD;
present on the pharmaceutical market (2,3). At the same time, such dosage forms may have problems&#xD;
with both the bioavailability of the components and their potential interaction. That is why during the&#xD;
pharmaceutical development of such products it is very important to ensure the absence of any&#xD;
interaction between both the API and the excipients. For this purpose, it is important to have&#xD;
developed methods for the chromatographic separation of the API and impurities in such dosage&#xD;
forms</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

